ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627371; 2) Community: the network communities that were significantly associated with the response to NSC 627371; 3) Molecule: the relationships between components within communities and NSC 627371; 4) MDR: the compounds that were significantly associated with the NSC 627371.

NSC Compound Enrichment Correlation
NSC 758423 Amsacrine (USAN) 0.0342636096654271 0.13576792
NSC 758881 Orlistat (USAN) 0.0342636096654271 0.24509576
NSC 759178 Pipamperone 0.0342636096654271 0.32131631
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0342636096654271 0.26052459
NSC 166588 METHYLUNDECYLPIPERIDINE, TRANS 0.0385203205529754 0.44940284
NSC 278632 Null 0.0385203205529754 0.43097086
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0385203205529754 0.48607452
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.0385203205529754 0.64461092
NSC 46691 Null 0.0385203205529754 -0.39491569
NSC 53861 Null 0.0385203205529754 0.26284057
Total:113  Current:86    [First] [Prev] [Next] [Last]